Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population

American Journal of Surgical Pathology

Volumn 27, Issue 4, 2003, Pages 432-440

  Bismar, Tarek A ^a   Lewis Jr , James S ^a   Vollmer, Robin T ^b   Humphrey, Peter A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biopsy; Carcinoma; Perineural; Prostate; Stage

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NEEDLE BIOPSY; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE DISEASE; PROSTATECTOMY;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0037378688     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200304000-00002     Document Type: Article

References (48)

1. Ackerman DA, Barry JM, Wicklund RA, et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic lymph node metastasis at radical prostatectomy. J Urol 1993;150:1845-50.
2. Anderson PR, Hanlon AL, Patchefsky A, et al. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA<10 ng/ml treated with conformal external beam radiation therapy. Int J Radiat Oncol Biol Phys 1998;41:1087-92.
3. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of resected prostate carcinomas. Am J Clin Pathol 1996;105:667-70.
4. Badalament RA, Miller MC, Peller PA, et al. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. J Urol 1996;156:1375-80.
5. Bastaky SI, Walsh PC, Epstein JJ. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 1993;17:336-41.
6. Bonin SR, Hanlon AL, Lee WR, et al. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer 1997;79:75-80.
7. Bostwick DG, Qian JI, Bergstralh E, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155:1361-7.
8. Bostwick DG, Foster CS. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol 1999;17:222-72.
9. Carter HB, Walsh PC, Landis P, et al. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 2002;167:1231-4.
10. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
11. Catalona WJ, Smith DS, Ratliff TL, et al. Detection of organconfined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1991;324:1156-61.
12. Conrad S, Graefen M, Pichlmeier U, et al. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 1998;159:2023-9.
13. D'Amico AV, Whittington R, Malkowicz SB, et al. Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative specific antigen failure. Urology 1997;49(suppl 3A):23-30.
14. D'Amico AV, Wu Y, Chen M-H, et al. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol 2001;165:126-39.
15. D'Amico AV, Keshaviah A, Manola J, et al. Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2002;53:581-7.
16. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002;95:281-6.
17. De la Taille A, Rubin MA, Bagiella E, et al. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? J Urol 1999:162:103-6.
18. De la Taille A, Katz A, Bagiella E, et al. Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage. Urology 1999;54:1039-43.
19. Egan AJM, Bostwick DG. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol 1997;21:1495-500.
20. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer. JAMA 1994;271:368-74.
21. Epstein JI, Potter SR. The pathologic interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001;166:402-10.
22. Freedland SJ, Csathy GS, Dorey F, et al. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002;167:516-20.
23. Gardner TA, Lerner ML, Schlegel PN, et al. Microfocal prostate cancer: biopsy cancer volume does not predict actual tumor volume. Br J Urol 1998;81:839-43.
24. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:372-9.
25. Goto Y, Ohori M, Arakawa A, et al. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 1996;156:1059-63.
26. Grossfeld GD, Latini DM, Lubek DP, et al. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: result form CaPSURE. Urology 2002;59:560-5.
27. Grossklaus DJ, Coffey CS, Shappell SB, et al. Percent of cancer in the biopsy set predicts pathologic findings after prostatectomy. J Urol 2002;167:2032-6.
28. Holmes GF, Walsh PC, Pound CR, et al. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology 1999;53:752-6.
29. Huland H, Hammerer P, Henke RP, et al. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol 1996;155:1344-7.
30. Humphrey PA, Baty J, Keetch D. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer 1995;75(suppl):1842-4.
31. Humphrey PA, Keetch DW, Smith DS, et al. Prospective characterization of pathologic features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 1996;155:816-20.
32. Lewis JS Jr, Vollmer RT, Humphrey PA. Prostate needle biopsy carcinoma extent in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol 2002;118:442-50.
33. Ohori M, Maru N, Scardino PT, et al. Significance of perineural invasion (PNI) by prostate cancer in systematic needle biopsy [Abstract]. J Urol 2002;167(suppl):229.
34. O'Malley KJ, Pound CR, Walsh PC, et al. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology 2002;59:85-90.
35. Merrick GS, Butler WM, Galbreath RW, et al. Perineural invasion is not predictive of biochemical outcome following brachytherapy. Cancer J 2001;7:404-12.
36. Ravery V, Delmas V, Boccon-Gibod LA, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994;44:371-6.
37. Ravery V, Schmid H-P, Toublanc M, et al. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma? Cancer 1996;78:1079-84.
38. Rubin MA, Bassily H, Sanda M, et al. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Am J Surg Pathol 2000;24:183-9.
39. Sebo TJ, Cheville JC, Riehle DL, et al. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 2001;91:2196-204.
40. Sebo TJ, Cheville JC, Riehle DL, et al. Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer. Am J Surg Pathol 2002;26:431-9.
41. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994;152:1732-6.
42. Srigley JR, Amin MB, Bostwick DG, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med 2000;124:1034-9.
43. Thorson P, Vollmer RT, Arcangeli C, et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol 1998;11:543-51.
44. Tigrani VS, Bhargava V, Shrinohara K, et al. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 1999;54:689-93.
45. Ukimura O, Troncoso P, Ramirez EJ, et al. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension. J Urol 1996;159:1251-9.
46. Vargas SO, Jirontek M, Welch WR, et al. Perineural invasion in prostate needle biopsy specimens: correlation with extraprostatic extension at resection. Am J Clin Pathol 1999;111:223-8.
47. Wills ML, Sauvgeot J, Partin AW, et al. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998;51:759-64.
48. Zhou M, Shah R, Ingold C, et al. Simultaneous evaluation for presence of nerve and perineural invasion on prostate needle biopsy improve predictability for extraprostatic extension on radical prostatectomy [Abstract]. Mod Pathol 2002;15:189.